16S ribosomal RNA aminoacyl-tRNA binding site (16S rRNA A-site) (16S rRNA A-site)

The A-site (aminoacyl-tRNA binding site) of the 16S ribosomal RNA (rRNA) is a critical functional domain within the 30S small subunit of the bacterial ribosome. It serves as the decoding center where the ribosome ensures the accuracy of protein synthesis by monitoring the base-pairing between the mRNA codon and the tRNA anticodon (Ogle et al., 2001). This site is the primary target for several major classes of antibiotics, including aminoglycosides and tetracyclines, which are essential for treating a wide range of Gram-positive and Gram-negative bacterial infections (Magnet & Blanchard, 2005). Aminoglycosides bind to the conserved internal loop of the A-site, causing conformational shifts that lead to the incorporation of incorrect amino acids, resulting in the production of non-functional or toxic proteins. Tetracyclines also target the A-site but act by sterically hindering the binding of aminoacyl-tRNA, effectively halting protein elongation (Brodersen et al., 2000). Resistance to these drugs often involves the acquisition of 16S rRNA methyltransferases or mutations within the rRNA sequence that decrease drug affinity, posing a significant challenge in clinical settings. Furthermore, the high degree of conservation in this region across bacterial species makes it an ideal target for broad-spectrum antimicrobial therapy. Structural studies have revealed that the binding of these drugs to the A-site exploits the unique architecture of bacterial rRNA, providing a basis for selective toxicity over eukaryotic ribosomes.

Other names

Decoding center16S rRNA decoding site30S ribosomal A-siteAminoacyl-tRNA binding siteBacterial decoding site30S A-site

Antibiotics targeting the 16S rRNA A-site interfere with the decoding process of translation. Aminoglycosides bind to the internal loop of the A-site, inducing a conformational change in residues A1492 and A1493 that stabilizes near-cognate tRNA binding, leading to mRNA misreading and mistranslation (Vicens & Westhof, 2001; Magnet & Blanchard, 2005). Tetracyclines bind to the A-site and physically block the docking of aminoacyl-tRNA, thereby preventing the addition of new amino acids to the growing polypeptide chain (Brodersen et al., 2000).